Kibbutz Glil Yam
Central District
Tel Aviv 4690500
Israel
https://imcannabis.com
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 95
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Marc Lustig M.B.A., M.Sc. | Executive Chairman | 95.03k | N/D | 1974 |
Mr. Oren Shuster | CEO & Director | 348.36k | N/D | N/D |
Mr. Uri Birenberg | Chief Financial Officer | 238.24k | N/D | 1976 |
Mr. Richard Balla | Chief Executive Officer of Adjupharm | 215.02k | N/D | N/D |
Advocate Michal Lebovitz Nissimov | General Counsel | N/D | N/D | N/D |
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.
La calificación ISS Governance QuickScore de IM Cannabis Corp. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.